Eric Feldman

Eric Feldman currently serves as the Director of the Early Phase Clinical Trial Program at Montefiore Einstein Cancer Center since November 2022. Previously, Eric held the position of Chief Medical Officer at Ichnos Sciences from November 2021 to May 2023. Prior to that, Eric was the Senior Vice President and Chief Medical Officer at GlycoMimetics for a brief period in 2021 and had an earlier tenure as Vice President of Clinical Development at the same company from April 2019 to November 2021. Eric also served as Chief Medical Officer and Senior Vice President of Clinical Development at Amphivena Therapeutics Inc. from August 2017 to April 2019, and as Senior Medical Director and Distinguished Clinical Scientist at Seattle Genetics from December 2014 to August 2017. Earlier in their career, Eric was a Professor of Medicine and Director of the Hematologic Malignancies Program at Weil-Cornell Medical College/New York Presbyterian Hospital from May 1999 to December 2014. Eric Feldman earned a Doctor of Medicine degree from New York Medical College between 1977 and 1981.